Human ClinicalPhenotype Associated with FOXN1 Mutations

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 665)

Abstract

In humans, a proper immune response relies on the innate immunity, characterized by a rapid and nonspecific initial response to infections and later on the adaptive immunity, characterized by a specific response to a particular antigen. Disruption of any part of the orchestrated immune response results in the inability to control infections and, subsequently, in illness. An impairment of both effector arms of the specific immunity characterizes the clinical phenotype, known as severecombined immunodeficiency (SCID), which represents a heterogeneous group of inherited disorders due to abnormalities of T, Band NK cells. The first congenital SCID was described as spontaneous immunodeficiency in 1966 in mice and referred as Nude/SCID, based on the association of athymia with complete hairless. In 1996, the human equivalent of the murine Nude/SCID phenotype (MIM #601705) was reported. As in mice, also in humans this form is characterized by an intrinsic defect of the thymus, congenital alopecia and nail dystrophy and is due to mutations of the FOXN1 gene, as well. FOXN1 is mainly expressed in the thymus and skin epithelial cells, where it plays a critical role in differentiation and survival. FOXN1 belongs to the forkhead box (FOX) gene family that comprises a diverse group of ‘winged helix’ transcription factors involved in development, metabolism, cancer and aging. These transcription factors share the common property of being developmentally regulated and of directing tissue specific transcription and cell fate decisions. In immune system, alterations of FOXN1 result in a thymus anlage that lacks the capacity to generate mature and functional thymocytes. Because the significant expression levels of FOXN1 in skin elements, keratinocytes have been successfully used to support a full process of human T-cell development in vitro, resulting in the generation of mature T-cells from hematopoietic precursor cells (HPCs). This finding would imply a role for skin as a primary lymphoid organ. Thus, the present chapter will focus on the information that came out from the original description of the human Nude/SCID phenotype and on the role of FOXN1 and of the other members of FOX subfamilies in those immunological disorders characterized by abnormal T-cell development or abnormal T-cell regulatory homeostasis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol 2003; 111:S571–581.CrossRefGoogle Scholar
  2. 2.
    Pignata C, Fiore M, Guzzetta V et al. Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet 1996; 65:167–170.CrossRefPubMedGoogle Scholar
  3. 3.
    Pignata C. A lesson to unraveling complex aspects of novel immunodeficiencies from the human equivalent of the nude/SCID phenotype. Journal of Hematotherapy and Stem Cell Research 2002; 11:409–414.CrossRefPubMedGoogle Scholar
  4. 4.
    Flanagan SP. ‘Nude’, a new hairless gene with pleiotropic effects in the mouse. Genet Res 1966; 8:295–309.CrossRefPubMedGoogle Scholar
  5. 5.
    Schlake T. The nude gene and the skin. Exp Dermatol 2001; 10:293–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Takahashi Y, Shimizu A, Sakai T et al. Mapping of the nu gene using congenic nude strains and in situ hybridization. J Exp Med 1992; 175:873–876.CrossRefPubMedGoogle Scholar
  7. 7.
    Byrd LG. Regional localization of the nu mutation on chromosome 11. Immunogenetics 1993; 37:157–159.CrossRefPubMedGoogle Scholar
  8. 8.
    Nehls M, Pfeifer D, Schorpp M et al. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 1994; 372:103–107.CrossRefPubMedGoogle Scholar
  9. 9.
    Pantelouris EM. Athymic development in the mouse. Differentiation 1973; 1:437–450.CrossRefPubMedGoogle Scholar
  10. 10.
    Köpf-Maier P, Mboneko VF. Anomalies in the hormonal status of athymic nude mice. J Cancer Res Clin Oncol 1990; 116:229–231.CrossRefPubMedGoogle Scholar
  11. 11.
    Mecklenburg L, Tychsen B, Paus R. Learning from nudity: lessonsfrom the nude phenotype. Exp Dermatol 2005; 14:797–810.CrossRefPubMedGoogle Scholar
  12. 12.
    Buhl AE, Waldon DJ, Miller BF et al. Differencesin activity of minoxidil and cyclosporinA on hair growth in nude and normal mice. Comparisons of in vivo and in vitro studies. Lab Invest 1990; 62:104–107.PubMedGoogle Scholar
  13. 13.
    Danilenko DM, Ring BD, Yanagihara D et aI. Keratinocyte growth factor is an important endogenous mediator of hair follicle growth, development and differentiation. Am J Pathol 1995; 147:145–154.PubMedGoogle Scholar
  14. 14.
    Brissette JL, Li J, Kamimura J et al, The product of the mouse nude locus, Whn, regulates the balance between epithelial cell growth and differentiation. Genes and Dev 1996; 10:2212–2221.CrossRefPubMedGoogle Scholar
  15. 15.
    Lee D, Prowse DM, Brissette JL. Association between mouse nude gene expression and the initiation of epithelial terminal differentiation. Dev Biol 1999; 208:362–374.CrossRefPubMedGoogle Scholar
  16. 16.
    Nehls M, Kyewski B, Messerle M et al, Two genetically separable steps in the differentiation of thymic epithelium. Science 1996; 272:886–889.CrossRefPubMedGoogle Scholar
  17. 17.
    Eaton GJ. Hair growth cycles and wave patterns in “nude” mice. Transplantation 1976; 22:217–222.CrossRefPubMedGoogle Scholar
  18. 18.
    Gershwin ME. DiGeorge syndrome: congenital thymic hypoplasia. Animal model: congenitally athymic (nude) mouse. Am J Pathol 1977; 89:809–812.PubMedGoogle Scholar
  19. 19.
    Conner JM, Gatherer D, Gray FC et al. Assignment of the gene for dyskeratosiscongenita to Xq28. Hum Genet 1986; 72:348–351.CrossRefGoogle Scholar
  20. 20.
    Arngrimsson R, Dokal I, Luzzatto L et al. Dyskeratosis congenita: three additional families show linkage to a locus in Xq28. J Med Genet 1993; 30:618–619.CrossRefPubMedGoogle Scholar
  21. 21.
    Ortega JA, Swanson VL, Landig BH et al. Congenital dyskeratosis: Zinner-Engman-Cole syndrome with thymic dysplasia and aplastic anemia. Am J Dis Child 1972; 124:701–704.PubMedGoogle Scholar
  22. 22.
    Lee BW, Yap HK, Quah TC et al. T-cell immunodeficiency in dyskeratosis congenita. Arch Dis Child 1992; 67:524–526.CrossRefPubMedGoogle Scholar
  23. 23.
    Frank J, Pignata C, Panteleyev AA et al. Exposing the human nude phenotype. Nature 1999; 398:473–474.CrossRefPubMedGoogle Scholar
  24. 24.
    Festing MFW, May D, Connors TA et al. An athymic nude mutation in the rat. Nature 1978; 274:365–366.CrossRefPubMedGoogle Scholar
  25. 25.
    Huth M, Schlake T, Boehm T. Transposon-induced splicing defect in the rat nude gene. Immunogenetics 1997; 45:282–283.CrossRefPubMedGoogle Scholar
  26. 26.
    Hofmann M, Harris M, Juriloff D et al. Spontaneous mutations in SELH/Bc mice due to insertions of early transposons: molecular characterization of null alleles at the nude and albino loci. Genomics 1998; 52:107–109.CrossRefGoogle Scholar
  27. 27.
    Adriani M, Martinez-Mir A, Fusco F et al. Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population. Ann Hum Genet 2004; 68:265–268.CrossRefPubMedGoogle Scholar
  28. 28.
    Auricchio L, Adriani M, Frank J et al. Nail distrophy associated with a heterozygous mutation of the Nude/SCID human FOXN1 (WHN) gene. Arch Dermatol 2005; 141:647–648.CrossRefPubMedGoogle Scholar
  29. 29.
    Amorosi S, D’Armienro M, Calcagno G et al. FOXN1 homozygous mutation associatedwith anencephaly and severe neural tube defect in human athymic Nude/SCID fetus. Clin Genet 2008; 73:380–384.CrossRefPubMedGoogle Scholar
  30. 30.
    Lai E, Clark KL, Burley SK et al. Hepatocyte nuclear factor 3/fork head or “winged helix” proteins: a family of transcription factors of diverse biologic function. Proc Natl Acad Sci 1993; 90:10421–10423.CrossRefPubMedGoogle Scholar
  31. 31.
    Kaestner KH, Knochel W, Martinez DE. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev 2000; 14:142–146.PubMedGoogle Scholar
  32. 32.
    Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 2002; 250:1–23.CrossRefPubMedGoogle Scholar
  33. 33.
    Coffer PJ, Burgering BMT. Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 2004; 4:889–899.CrossRefPubMedGoogle Scholar
  34. 34.
    Lehmann OJ, Sowden JC, Carlsson P et al. Fox’s in development and disease. Trends Genet 2003; 19:339–344.CrossRefPubMedGoogle Scholar
  35. 35.
    Shevach EM, McHugh RS, Piccirillo CA et al. Control of T-cell activation by CD4+ CD25+ suppressor T-cells. Immunol Rev 2001; 182:58–67.CrossRefPubMedGoogle Scholar
  36. 36.
    Asano M, Toda M, Sakaguchi N et al. Autoimmune diseaseas a consequence of developmental abnormality of a T-cell subpopulation. J Exp Med 1996; 184:387–396.CrossRefPubMedGoogle Scholar
  37. 37.
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 2003; 299:1057–1061.CrossRefPubMedGoogle Scholar
  38. 38.
    Hori S, Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T-cells. Microbes Infect 2004; 6:745–751.CrossRefPubMedGoogle Scholar
  39. 39.
    Blair PJ, Bultman SJ, Haas JC et al. CD4+CD8-T-cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153:3764–3774.PubMedGoogle Scholar
  40. 40.
    Godfrey VL, Wilkinson JE, Rinchik EM et al. Fatallymphoreticular disease in the scurfy (sf) mouse requires T-cells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci USA 1991; 88:5528–5532.CrossRefPubMedGoogle Scholar
  41. 41.
    Ramsdell F. Foxp3 and natural regulatory T-cells: key to a cell lineage? Immunity 2003; 19:165–168.CrossRefPubMedGoogle Scholar
  42. 42.
    Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25 naive T-cells to CD4+CD25+ regulatory T-cells by TGF-β induction of transcription factor Foxp3. J Exp Med 2003; 198:1875–1886.CrossRefPubMedGoogle Scholar
  43. 43.
    Fantini MC, Becker C, Monteleone G et al. Cutting edge: TGF-β induces a regulatory phenotype in CD4+Cd25 T-cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149–5153.PubMedGoogle Scholar
  44. 44.
    Jacobs FM, van der Heide LP, Wijchers PJ et al. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem 2003; 278:35959–35967.CrossRefPubMedGoogle Scholar
  45. 45.
    Tran H, Brunet A, Griffith EC et aI. The many forks in FOXO’s road. Sci STKE 2003; 2003:RE5.CrossRefPubMedGoogle Scholar
  46. 46.
    Burgering BMT, Kops GJPL. Cell cycle and death control: long live forkheads. Trends Biochem Sci 2002; 27:352–360.CrossRefPubMedGoogle Scholar
  47. 47.
    Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation and transformation. Cell 2004; 117:421–426.CrossRefPubMedGoogle Scholar
  48. 48.
    Kitamura T, Nakae J, Kitamura Y et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdxl regulation of pancreatic β-cell growth. J Clin Invest 2002; 110:1839–1847.PubMedGoogle Scholar
  49. 49.
    Nakae J, Kitamura T, Kitamura Y et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 2003; 4:119–129.CrossRefPubMedGoogle Scholar
  50. 50.
    Furuyama T, Kitayama K, Shimoda Y et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 2004; 279:34741–34749.CrossRefPubMedGoogle Scholar
  51. 51.
    Castrillon DH, Miao L, Kollipara R et al. Suppession of ovarian follicleactivation in mice by the transcription factor Foxeda. Science 2003; 301:215–218.CrossRefPubMedGoogle Scholar
  52. 52.
    Hosaka T, Biggs III WH, Tieu D et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 2004; 101:2975–2980.CrossRefPubMedGoogle Scholar
  53. 53.
    Brenkman AB, Burgering BMT. FoxO3a eggs on fertility and aging. Trends Mol Med 2003; 9:464–467.CrossRefPubMedGoogle Scholar
  54. 54.
    Brunet A, Bonni A, Zigmond MJ et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999; 96:857–868.CrossRefPubMedGoogle Scholar
  55. 55.
    Biggs III WH, Meisenhelder J, Hunter T et al. Protein kinase B/Akt-mediated phosphorylation promotes nuclear, exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci USA 1999; 96:7421–7426.CrossRefPubMedGoogle Scholar
  56. 56.
    Kops GJPL, de Ruiter ND, De Vries-Smits AMM et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 1999; 398:630–634.CrossRefPubMedGoogle Scholar
  57. 57.
    Takaishi H, Konishi H, Matsuzaki H et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 1999; 96:11836–11841.CrossRefPubMedGoogle Scholar
  58. 58.
    Stahl M, Dijkers PF, Kops GJPL et al. The forkhead transcription factor FoxO regulates transcription of p27kip1 and Bim in responce to IL-2. J Immunol 2002; 168:502;4–5031.Google Scholar
  59. 59.
    Yusuf I, Zhu X, Kharas MG et al. Optimal B-cellproliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 2004; 104:784–787.CrossRefPubMedGoogle Scholar
  60. 60.
    Matsuzaki H, Daitoku H, Hatra M et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasome degradation. Proc Natl Acad Sci USA 2003; 100:11285–11290.CrossRefPubMedGoogle Scholar
  61. 61.
    Plas DR, Thompson CB. Ala activation promotes degradation of tuberin and FOX03a via the proteasome. J Biol Chem 2003; 278:12361–12366.CrossRefPubMedGoogle Scholar
  62. 62.
    Lin L, Hron JD, Peng SL. Regulation of NF-kB, Th activation and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004; 21:203–213.CrossRefPubMedGoogle Scholar
  63. 63.
    Chen J, Knowles HJ, Hebert JL et al. Mutation of the mouse hepatocyte nuclear factor/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry. J Clin Invest 1998; 102:1077–1082.CrossRefPubMedGoogle Scholar
  64. 64.
    Blatt EN, Yan XH, Wuerffel MK et al. Forkhead transcription factor HFH-4 expression is temporally related to ciliogenesis. Am J Respir Cell Mol Biol 1999; 21:168–176.PubMedGoogle Scholar
  65. 65.
    Brody SL, Yan XH, Wuerffel MK et al. Ciliogenesis and left-right axis defects in forkhead factor HFH-4-null mice. Am J Respir Cell Mol Biol 2000; 23:45–51.PubMedGoogle Scholar
  66. 66.
    Okada A, Ohta Y, Brody SL et al. Role of Foxj1 and estrogen receptor alpha in ciliated epithelial cell differentiation of the neonatal oviduct. J Mol Endocrinol 2004; 32:615–625.CrossRefPubMedGoogle Scholar
  67. 67.
    Clevidence DE, Overdier DG, Peterson RS et al. Members of the HNF-3/forkhead family of transcription factors exhibit distinct cellular expression patterns in lung and regulate the surfactant protein B promoter. Dev Biol 1994; 166:195–209.CrossRefPubMedGoogle Scholar
  68. 68.
    Lin L, Spoor MS, Gerth AJ et al. Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science 2004; 303:1017–1020.CrossRefPubMedGoogle Scholar
  69. 69.
    Jonsson H, Peng SL. Forkhead transcription factors in immunology. CMLS Cell Mol Life Sci 2005; 62:397–409.CrossRefGoogle Scholar
  70. 70.
    Schorpp M, Hoffmann M, Dear TN et al. Characterization of mouse and human nude genes. Immunogenetics 1997; 46:509–515.CrossRefPubMedGoogle Scholar
  71. 71.
    Balciunaite G, Keller MP, Balciunaite E et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat immunol 2002; 3:1102–1108.CrossRefPubMedGoogle Scholar
  72. 72.
    Tsai PT, Lee RA, Wu H. BMP4 acts upstream of FGF in modulating thymic stroma and regulating thymopoiesis. Blood 2003; 102:3947–3953.CrossRefPubMedGoogle Scholar
  73. 73.
    Ye H, Kelly TF, Samadani U et al. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 1997; 17:1626–1641.PubMedGoogle Scholar
  74. 74.
    Janes SM, Ofstad TA, Campbell DH et al. Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt. J Cell Sci 2004; 117:41–4168.CrossRefGoogle Scholar
  75. 75.
    Schlake T, Schorpp M, Maul-Pavicic A et al. Forkhead/Winged-Helix transcription factor Whn regulates hair keratin gene expression: molecular analysis of the Nude skin phenotype. Dev Dyn 2000; 217:368–376.CrossRefPubMedGoogle Scholar
  76. 76.
    Boehm T. Thymus development and function. Curr Opin Immunol 2008; 20:178–184.CrossRefPubMedGoogle Scholar
  77. 77.
    Heitger A, Neu N, Kern H et al. Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997; 90:850–8.PubMedGoogle Scholar
  78. 78.
    Blackburn CC, Manley NR, Palmer DB et al. One for all and all for one: thymic epithelial stem cells and regeneration. Trends immunol 2002; 23:391–395.CrossRefPubMedGoogle Scholar
  79. 79.
    Manley NR, Blackburn CC. A developmental look at thymus organogenesis: where do the nonhematopoietic cells in the thymus come from? Curr Opin Immunol 2003; 15:225–232.CrossRefPubMedGoogle Scholar
  80. 80.
    Gordon J, Wilson VA, Blair NF et al. Functional evidence for a single endodermal origin for the thymic epithelium. Nat Immunol 2004; 5:5–553.CrossRefGoogle Scholar
  81. 81.
    Bleul CC, Boehm T. Chemokines define distinct microenvironments in the developing thymus. Eur J Immunol 2000; 30:3371–3379.CrossRefPubMedGoogle Scholar
  82. 82.
    Hardy MH. The secret life of the hair follicle. Trends Genet 1992; 8:55–61.PubMedGoogle Scholar
  83. 83.
    Clark RA, Yamanaka K, Bai M et al. Human skin cells support thymus-indipendent T-cell development. J Clin Invest 2005; 115:3239–3249.CrossRefPubMedGoogle Scholar
  84. 84.
    Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690–695.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer+Business Media 2009

Authors and Affiliations

  1. 1.Department of Pediatrics, Unit of Immunology“Federico II” UniversityNaplesItaly

Personalised recommendations